PROSTAMAX 20 MG

What is Prostamax?

Prostamax (KEDP; Lys-Glu-Asp-Pro) is a synthetic Khavinson bioregulator peptide that has been investigated in laboratory and preclinical research for its potential effects on prostate tissue, cellular aging, and gene regulation. 

What is Prostamax studied for?

Research has explored Prostamax for:

• Benign Prostatic Hyperplasia (BPH) – age-related prostate enlargement
• Chronic prostatitis – prostate inflammation
• Urinary function – frequency, urgency, and urinary flow
• Prostate tissue regeneration
• Anti-inflammatory effects within prostate tissue
• Cellular aging (gerontology) through proposed epigenetic mechanisms
• Gene expression/chromatin regulation in prostate and immune cells

Proposed mechanism

Researchers have suggested Prostamax may:

• Modulate gene expression through chromatin interactions
• Reduce inflammatory signaling
• Support normal prostate cell function
• Help maintain healthy prostate tissue during aging

What is Prostamax commonly stacked with (research context)?

In research settings and among peptide enthusiasts, Prostamax is commonly discussed alongside other Khavinson bioregulators and longevity-focused compounds, including:

• Testagen – reproductive/endocrine support
• Vesugen – vascular health research
• Pinealon – cognitive and neuroprotection research
• Epitalon – longevity and healthy aging research
• Chitomur – bladder and urinary tract research
• Vesilute – urinary system support
• Cartalax – connective tissue/cartilage research

Researchers interested in prostate biology also often combine it conceptually with studies of:

• Testosterone optimization
• Estrogen balance
• DHT regulation
• General healthy-aging protocols

Current evidence

Because of the limited evidence, Prostamax should be viewed as an experimental research peptide rather than an established medical treatment.